Conley Chee

Companies

• Syros Pharmaceuticals, Inc.Board member Dec 5, 2023 to Nov 20, 2024¹
• Syros Pharmaceuticals, Inc.Chief executive officer Dec 5, 2023 to Nov 20, 2024¹
• Syros Pharmaceuticals, Inc.President Dec 5, 2023 to Nov 20, 2024¹
• Syros Pharmaceuticals, Inc.Chief Commercial Officer Sep 28, 2021 to Nov 2, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSyros Pharmaceuticals, Inc.0 shares³Nov 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 18, 2024Sold 134,797 shares at $0.20 of Syros Pharmaceuticals, Inc.³
• Oct 31, 2024Shares withheld for tax 8,707 shares at $2.09 of Syros Pharmaceuticals, Inc.⁴
• Oct 31, 2024Exercised options 17,000 shares of Syros Pharmaceuticals, Inc.⁴
• Sep 11, 2024Bought 50,000 shares at $1.71 of Syros Pharmaceuticals, Inc.⁵
• Sep 10, 2024Bought 50,000 shares at $1.51 of Syros Pharmaceuticals, Inc.⁵
• Apr 1, 2024Shares withheld for tax 3,500 shares at $5.12 of Syros Pharmaceuticals, Inc.⁶
• Mar 31, 2024Exercised options 11,666 shares of Syros Pharmaceuticals, Inc.⁶
• Mar 31, 2024Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.⁶
• Nov 1, 2023Shares withheld for tax 6,004 shares at $2.22 of Syros Pharmaceuticals, Inc.⁷
• Oct 31, 2023Exercised options 17,000 shares of Syros Pharmaceuticals, Inc.⁷
• Apr 3, 2023Shares withheld for tax 658 shares at $2.58 of Syros Pharmaceuticals, Inc.⁸
• Mar 31, 2023Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.⁸